SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001640334-21-001707
Filing Date
2021-07-29
Accepted
2021-07-28 20:02:38
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 skye_s3.htm S-3 222573
2 OPINION OF GREENBERG TRAURIG skye_ex51.htm EX-5.1 22626
3 CONSENT skye_ex231.htm EX-23.1 2556
4 skye_ex51img1.jpg GRAPHIC 4133
5 skye_s3img1.jpg GRAPHIC 7448
6 skye_s3img2.jpg GRAPHIC 7736
  Complete submission text file 0001640334-21-001707.txt   276005
Mailing Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121
Business Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121 (949) 480-9051
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-258243 | Film No.: 211124345
SIC: 2834 Pharmaceutical Preparations